These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 26714866

  • 1. Modulation of post-stroke degenerative and regenerative processes and subacute protection by site-targeted inhibition of the alternative pathway of complement.
    Alawieh A, Elvington A, Zhu H, Yu J, Kindy MS, Atkinson C, Tomlinson S.
    J Neuroinflammation; 2015 Dec 30; 12():247. PubMed ID: 26714866
    [Abstract] [Full Text] [Related]

  • 2. The alternative complement pathway propagates inflammation and injury in murine ischemic stroke.
    Elvington A, Atkinson C, Zhu H, Yu J, Takahashi K, Stahl GL, Kindy MS, Tomlinson S.
    J Immunol; 2012 Nov 01; 189(9):4640-7. PubMed ID: 23028050
    [Abstract] [Full Text] [Related]

  • 3. A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia/reperfusion injury.
    Huang Y, Qiao F, Atkinson C, Holers VM, Tomlinson S.
    J Immunol; 2008 Dec 01; 181(11):8068-76. PubMed ID: 19017999
    [Abstract] [Full Text] [Related]

  • 4. A targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degeneration.
    Rohrer B, Long Q, Coughlin B, Wilson RB, Huang Y, Qiao F, Tang PH, Kunchithapautham K, Gilkeson GS, Tomlinson S.
    Invest Ophthalmol Vis Sci; 2009 Jul 01; 50(7):3056-64. PubMed ID: 19264882
    [Abstract] [Full Text] [Related]

  • 5. Targeted complement inhibitors protect against posttransplant cardiac ischemia and reperfusion injury and reveal an important role for the alternative pathway of complement activation.
    Atkinson C, He S, Morris K, Qiao F, Casey S, Goddard M, Tomlinson S.
    J Immunol; 2010 Dec 01; 185(11):7007-13. PubMed ID: 20962256
    [Abstract] [Full Text] [Related]

  • 6. Deficiency of complement receptors CR2/CR1 in Cr2⁻/⁻ mice reduces the extent of secondary brain damage after closed head injury.
    Neher MD, Rich MC, Keene CN, Weckbach S, Bolden AL, Losacco JT, Patane J, Flierl MA, Kulik L, Holers VM, Stahel PF.
    J Neuroinflammation; 2014 May 24; 11():95. PubMed ID: 24885042
    [Abstract] [Full Text] [Related]

  • 7. Complement-dependent P-selectin expression and injury following ischemic stroke.
    Atkinson C, Zhu H, Qiao F, Varela JC, Yu J, Song H, Kindy MS, Tomlinson S.
    J Immunol; 2006 Nov 15; 177(10):7266-74. PubMed ID: 17082645
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The benefit of targeted and selective inhibition of the alternative complement pathway for modulating autoimmunity and renal disease in MRL/lpr mice.
    Sekine H, Kinser TT, Qiao F, Martinez E, Paulling E, Ruiz P, Gilkeson GS, Tomlinson S.
    Arthritis Rheum; 2011 Apr 15; 63(4):1076-85. PubMed ID: 21452327
    [Abstract] [Full Text] [Related]

  • 10. Targeted inhibition of the complement alternative pathway with complement receptor 2 and factor H attenuates collagen antibody-induced arthritis in mice.
    Banda NK, Levitt B, Glogowska MJ, Thurman JM, Takahashi K, Stahl GL, Tomlinson S, Arend WP, Holers VM.
    J Immunol; 2009 Nov 01; 183(9):5928-37. PubMed ID: 19828624
    [Abstract] [Full Text] [Related]

  • 11. Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection.
    Atkinson C, Song H, Lu B, Qiao F, Burns TA, Holers VM, Tsokos GC, Tomlinson S.
    J Clin Invest; 2005 Sep 01; 115(9):2444-53. PubMed ID: 16127466
    [Abstract] [Full Text] [Related]

  • 12. Targeted Complement Inhibition Protects Vascularized Composite Allografts From Acute Graft Injury and Prolongs Graft Survival When Combined With Subtherapeutic Cyclosporine A Therapy.
    Zhu P, Bailey SR, Lei B, Paulos CM, Atkinson C, Tomlinson S.
    Transplantation; 2017 Apr 01; 101(4):e75-e85. PubMed ID: 28045880
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Complement Inhibition Alleviates Cholestatic Liver Injury Through Mediating Macrophage Infiltration and Function in Mice.
    Guo Z, Chen J, Zeng Y, Wang Z, Yao M, Tomlinson S, Chen B, Yuan G, He S.
    Front Immunol; 2021 Apr 01; 12():785287. PubMed ID: 35069557
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inhibition of the alternative complement pathway accelerates repair processes in the murine model of choroidal neovascularization.
    Parsons N, Annamalai B, Obert E, Schnabolk G, Tomlinson S, Rohrer B.
    Mol Immunol; 2019 Apr 01; 108():8-12. PubMed ID: 30763805
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Complement plays an important role in spinal cord injury and represents a therapeutic target for improving recovery following trauma.
    Qiao F, Atkinson C, Song H, Pannu R, Singh I, Tomlinson S.
    Am J Pathol; 2006 Sep 01; 169(3):1039-47. PubMed ID: 16936276
    [Abstract] [Full Text] [Related]

  • 20. Regulatable Complement Inhibition of the Alternative Pathway Mitigates Wet Age-Related Macular Degeneration Pathology in a Mouse Model.
    Parsons NB, Annamalai B, Rohrer B.
    Transl Vis Sci Technol; 2023 Jul 03; 12(7):17. PubMed ID: 37462980
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.